Drugging the R-loop interactome: RNA-DNA hybrid binding proteins as targets for cancer therapy.

[1]  R. Coulombe,et al.  Prevalent , 2020, Definitions.

[2]  K. Cimprich,et al.  R-Loops as Cellular Regulators and Genomic Threats. , 2019, Molecular cell.

[3]  P. Sung,et al.  Binding of FANCI-FANCD2 Complex to RNA and R-Loops Stimulates Robust FANCD2 Monoubiquitination , 2019, Cell reports.

[4]  Santhilata Kuppili Venkata,et al.  The Network of Cancer Genes (NCG): a comprehensive catalogue of known and candidate cancer genes from cancer sequencing screens , 2018, Genome Biology.

[5]  C. Niehrs,et al.  GADD45A binds R-loops and recruits TET1 to CpG island promoters , 2018, Nature Genetics.

[6]  G. Capranico,et al.  DNA damage and genome instability by G-quadruplex ligands are mediated by R loops in human cancer cells , 2018, Proceedings of the National Academy of Sciences.

[7]  C. Galmarini,et al.  The Antitumor Drugs Trabectedin and Lurbinectedin Induce Transcription-Dependent Replication Stress and Genome Instability , 2018, Molecular Cancer Research.

[8]  K. Hiom,et al.  DHX9 helicase promotes R-loop formation in cells with impaired RNA splicing , 2018, Nature Communications.

[9]  H. Chon,et al.  Two RNase H2 Mutants with Differential rNMP Processing Activity Reveal a Threshold of Ribonucleotide Tolerance for Embryonic Development , 2018, Cell reports.

[10]  S. Balasubramanian,et al.  DNA G-quadruplex structures mould the DNA methylome , 2018, Nature Structural & Molecular Biology.

[11]  Y. Pommier,et al.  Endogenous single-strand DNA breaks at RNA polymerase II promoters in Saccharomyces cerevisiae , 2018, Nucleic acids research.

[12]  Joshua T. Burdick,et al.  Human proteins that interact with RNA/DNA hybrids , 2018, Genome research.

[13]  N. Gromak,et al.  RNA/DNA Hybrid Interactome Identifies DXH9 as a Molecular Player in Transcriptional Termination and R-Loop-Associated DNA Damage , 2018, Cell reports.

[14]  K. Stegmaier,et al.  EWS–FLI1 increases transcription to cause R-loops and block BRCA1 repair in Ewing sarcoma , 2018, Nature.

[15]  E. Ruggiero,et al.  G-quadruplexes and G-quadruplex ligands: targets and tools in antiviral therapy , 2018, Nucleic acids research.

[16]  C. Shao,et al.  The Augmented R-Loop Is a Unifying Mechanism for Myelodysplastic Syndromes Induced by High-Risk Splicing Factor Mutations. , 2018, Molecular cell.

[17]  T. Bowman,et al.  Spliceosomal components protect embryonic neurons from R-loop-mediated DNA damage and apoptosis , 2018, Disease Models & Mechanisms.

[18]  Jonathan L Chen,et al.  Using Genome Sequence to Enable the Design of Medicines and Chemical Probes. , 2018, Chemical reviews.

[19]  Jason Roszik,et al.  High-Throughput Architecture for Discovering Combination Cancer Therapeutics , 2018, JCO clinical cancer informatics.

[20]  T. Riera,et al.  Identification of a CARM1 Inhibitor with Potent In Vitro and In Vivo Activity in Preclinical Models of Multiple Myeloma , 2017, Scientific Reports.

[21]  Samuel E. Jones,et al.  ATR Is a Therapeutic Target in Synovial Sarcoma. , 2017, Cancer research.

[22]  Steven J. M. Jones,et al.  RECQ-like helicases Sgs1 and BLM regulate R-loop–associated genome instability , 2017, The Journal of cell biology.

[23]  R. Maul,et al.  R-Loop Depletion by Over-expressed RNase H1 in Mouse B Cells Increases Activation-Induced Deaminase Access to the Transcribed Strand without Altering Frequency of Isotype Switching. , 2017, Journal of molecular biology.

[24]  J. Manley,et al.  R Loops and Links to Human Disease. , 2017, Journal of molecular biology.

[25]  N. Gromak,et al.  Senataxin: Genome Guardian at the Interface of Transcription and Neurodegeneration. , 2017, Journal of molecular biology.

[26]  A. Shibata,et al.  Aquarius is required for proper CtIP expression and homologous recombination repair , 2017, Scientific Reports.

[27]  Nicola J. Rinaldi,et al.  Enhancing GTEx by bridging the gaps between genotype, gene expression, and disease , 2017, Nature Genetics.

[28]  S. Crooke,et al.  Dynamic nucleoplasmic and nucleolar localization of mammalian RNase H1 in response to RNAP I transcriptional R-loops , 2017, Nucleic acids research.

[29]  E. Rajnavölgyi,et al.  RNA-DNA hybrid (R-loop) immunoprecipitation mapping: an analytical workflow to evaluate inherent biases. , 2017, Genome research.

[30]  Karim Mekhail,et al.  Ataxin-2: From RNA Control to Human Health and Disease , 2017, Genes.

[31]  Ruedi Aebersold,et al.  A Class of Environmental and Endogenous Toxins Induces BRCA2 Haploinsufficiency and Genome Instability , 2017, Cell.

[32]  D. Maiorano,et al.  An ATR‐dependent function for the Ddx19 RNA helicase in nuclear R‐loop metabolism , 2017, The EMBO journal.

[33]  J. Roszik,et al.  A tool for discovering drug sensitivity and gene expression associations in cancer cells , 2017, PloS one.

[34]  T. Owa,et al.  Selective degradation of splicing factor CAPERα by anticancer sulfonamides. , 2017, Nature chemical biology.

[35]  Sebastian Pott,et al.  PIF1 family DNA helicases suppress R-loop mediated genome instability at tRNA genes , 2017, Nature Communications.

[36]  Jian Xian,et al.  CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours , 2017, Nature Communications.

[37]  B. Monk,et al.  Trabectedin as a chemotherapy option for patients with BRCA deficiency. , 2016, Cancer treatment reviews.

[38]  Panagiotis Kotsantis,et al.  Increased global transcription activity as a mechanism of replication stress in cancer , 2016, Nature Communications.

[39]  Grant W. Brown,et al.  Intersection of calorie restriction and magnesium in the suppression of genome-destabilizing RNA–DNA hybrids , 2016, Nucleic acids research.

[40]  A. Nussenzweig,et al.  Efficacy of ATR inhibitors as single agents in Ewing sarcoma , 2016, Oncotarget.

[41]  Xiaoqin Xu,et al.  Prevalent, Dynamic, and Conserved R-Loop Structures Associate with Specific Epigenomic Signatures in Mammals. , 2016, Molecular cell.

[42]  Robert L. Grossman,et al.  A Case for Data Commons: Toward Data Science as a Service , 2016, Computing in Science & Engineering.

[43]  Martin A. M. Reijns,et al.  Ribonuclease H2 mutations induce a cGAS/STING‐dependent innate immune response , 2016, The EMBO journal.

[44]  Rachel M. Webster.  Combination therapies in oncology , 2016, Nature Reviews Drug Discovery.

[45]  M. Forcato,et al.  Dynamic Effects of Topoisomerase I Inhibition on R-Loops and Short Transcripts at Active Promoters , 2016, PloS one.

[46]  R. Gibbons,et al.  The Fanconi Anemia Pathway Maintains Genome Stability by Coordinating Replication and Transcription , 2015, Molecular cell.

[47]  I. V. Rosado,et al.  The Fanconi Anemia Pathway Protects Genome Integrity from R-loops , 2015, PLoS genetics.

[48]  A. Üren,et al.  YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse model , 2015, Oncotarget.

[49]  Xiaobin Zheng,et al.  Splicing function of mitotic regulators links R-loop–mediated DNA damage to tumor cell killing , 2015, The Journal of cell biology.

[50]  Manolis Kellis,et al.  BRCA1 Recruitment to Transcriptional Pause Sites Is Required for R-Loop-Driven DNA Damage Repair , 2015, Molecular cell.

[51]  K. Cimprich,et al.  Transcription-coupled nucleotide excision repair factors promote R-loop-induced genome instability. , 2014, Molecular cell.

[52]  D. Tollervey,et al.  Genome-Wide Distribution of RNA-DNA Hybrids Identifies RNase H Targets in tRNA Genes, Retrotransposons and Mitochondria , 2014, PLoS genetics.

[53]  A. Emili,et al.  Roles for Pbp1 and caloric restriction in genome and lifespan maintenance via suppression of RNA-DNA hybrids. , 2014, Developmental cell.

[54]  A. Aguilera,et al.  BRCA2 prevents R-loop accumulation and associates with TREX-2 mRNA export factor PCID2 , 2014, Nature.

[55]  K. Cimprich,et al.  The contribution of co-transcriptional RNA:DNA hybrid structures to DNA damage and genome instability. , 2014, DNA repair.

[56]  Konstantina Skourti-Stathaki,et al.  A double-edged sword: R loops as threats to genome integrity and powerful regulators of gene expression , 2014, Genes & development.

[57]  M. Disney,et al.  Promoter-Bound Trinucleotide Repeat mRNA Drives Epigenetic Silencing in Fragile X Syndrome , 2014, Science.

[58]  F. Chédin,et al.  Arginine methylation facilitates the recruitment of TOP3B to chromatin to prevent R loop accumulation. , 2014, Molecular cell.

[59]  Joshua M. Stuart,et al.  The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.

[60]  Peter Tsang,et al.  R-loop formation at Snord116 mediates topotecan inhibition of Ube3a-antisense and allele-specific chromatin decondensation , 2013, Proceedings of the National Academy of Sciences.

[61]  M. Christmann,et al.  Human three prime exonuclease TREX1 is induced by genotoxic stress and involved in protection of glioma and melanoma cells to anticancer drugs. , 2013, Biochimica et biophysica acta.

[62]  K. Mckinney,et al.  Senataxin Plays an Essential Role with DNA Damage Response Proteins in Meiotic Recombination and Gene Silencing , 2013, PLoS genetics.

[63]  K. Kinzler,et al.  Cancer Genome Landscapes , 2013, Science.

[64]  A. Jackson,et al.  Identification of Small-Molecule Inhibitors of the Ribonuclease H2 Enzyme , 2013, Journal of biomolecular screening.

[65]  Sridhar Ramaswamy,et al.  Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells , 2012, Nucleic Acids Res..

[66]  S. Boulton,et al.  RTEL1 Dismantles T Loops and Counteracts Telomeric G4-DNA to Maintain Telomere Integrity , 2012, Cell.

[67]  Andrés Aguilera,et al.  R loops: from transcription byproducts to threats to genome stability. , 2012, Molecular cell.

[68]  Adam A. Margolin,et al.  The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.

[69]  Katsuhiko Shirahige,et al.  Genome‐wide function of THO/TREX in active genes prevents R‐loop‐dependent replication obstacles , 2011, The EMBO journal.

[70]  J. Turchi,et al.  Targeted inhibition of Replication Protein A reveals cytotoxic activity, synergy with chemotherapeutic DNA-damaging agents, and insight into cellular function. , 2010, Cancer research.

[71]  T. Conrads,et al.  Abstract 3789: Elevated inorganic phosphate stimulates immediate early gene expression and requires FGF receptor signaling , 2010 .

[72]  S. Henderson,et al.  Genomics screen in transformed stem cells reveals RNASEH2A, PPAP2C, and ADARB1 as putative anticancer drug targets , 2009, Molecular Cancer Therapeutics.

[73]  Nicholas N. Shaw,et al.  Recognition of the unique structure of DNA:RNA hybrids. , 2008, Biochimie.

[74]  J. Vaquero,et al.  Relevance of the Fanconi anemia pathway in the response of human cells to trabectedin , 2008, Molecular Cancer Therapeutics.

[75]  G. Vereb,et al.  Ribonucleoprotein-masked nicks at 50-kbp intervals in the eukaryotic genomic DNA , 2007, Proceedings of the National Academy of Sciences.

[76]  V. Zakian,et al.  The yeast Pif1p DNA helicase preferentially unwinds RNA–DNA substrates , 2007, Nucleic acids research.

[77]  J. Manley,et al.  Inactivation of the SR Protein Splicing Factor ASF/SF2 Results in Genomic Instability , 2005, Cell.

[78]  M. Itaya,et al.  The absence of ribonuclease H1 or H2 alters the sensitivity of Saccharomyces cerevisiae to hydroxyurea, caffeine and ethyl methanesulphonate: implications for roles of RNases H in DNA replication and repair , 2000, Genes to cells : devoted to molecular & cellular mechanisms.

[79]  R. F. Weaver,et al.  Selectivity of F8-actinomycin D for RNA:DNA hybrids and its anti-leukemia activity. , 1997, Bioorganic & medicinal chemistry.